Assessing developability early in the discovery process for novel biologics

ML Fernández-Quintero, A Ljungars, F Waibl, V Greiff… - MAbs, 2023 - Taylor & Francis
Beyond potency, a good developability profile is a key attribute of a biological drug.
Selecting and screening for such attributes early in the drug development process can save …

Fit‐for‐purpose heterodivalent single‐domain antibody for gastrointestinal targeting of toxin B from Clostridium difficile

ER Rodriguez Rodriguez, RT Nordvang… - Protein …, 2024 - Wiley Online Library
Abstract Single‐domain antibodies (sdAbs), such as VHHs, are increasingly being
developed for gastrointestinal (GI) applications against pathogens to strengthen gut health …

[PDF][PDF] Fit-for-purpose heterodivalent single-domain antibody for gastrointestinal targeting of toxin B from

ERR Rodriguez, RT Nordvang, M Petersson… - 2024 - drive.google.com
Abstract Single-domain antibodies (sdAbs), such as VHHs, are increasingly being
developed for gastrointestinal (GI) applications against pathogens to strengthen gut health …